Skip to content

A comparison of intrathecal diamorphine and intravenous morphine for postoperative analgesia in patients undergoing lumbar spinal surgery

A comparison of intrathecal diamorphine and intravenous morphine for postoperative analgesia in patients undergoing lumbar spinal surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN01558905
Enrollment
80
Registered
2007-09-28
Start date
2006-01-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery: Analgesia Surgery Analgesia

Interventions

Intrathecal diamorphine vs intravenous morphine

Sponsors

Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All ASA 1,2 and 3 patients between the ages of 18 to 70 years undergoing lumbar spinal surgery via a posterior surgical approach will be invited to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Any contraindications to spinal injection (localised skin sepsis at proposed site of injection, coagulopathy) 2. History of allergy to any of the drugs used in the study 3. Severe hepatic or renal disease

Design outcomes

Primary

MeasureTime frame
The quality of postoperative analgesia. Patients pain scores will be measured in recovery and on days 1 and 2 postoperatively using a validated pain assessment tool (visual analogue scale 0-100mm). The assessor will be blinded to the patients treatment group. The amounts of morphine required to achieve adequate analgesia via a PCA system will be recorded in both groups.

Secondary

MeasureTime frame
Secondary outcome measures include the presence of nausea, vomiting, sedation and pruritis.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026